Apotheek Francois Claeys SRL
Apotheek Francois Claeys reported total assets of 217,999 € at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jun 2026).
The score of Apotheek Francois Claeys shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +94 % Total assets -9 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Francois Claeys's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jun 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 31 Dec 2023filed on 20 Jun 2024
- Year ended 31 Dec 2022filed on 22 Jun 2023
Apotheek Francois Claeys's financial analysis
- Solvency46.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Francois Claeys
Apotheek Francois Claeys's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0775.499.855
- VAT number
- BE0775499855
- Peppol
- Registered · 0208:0775499855 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Oct 2021
- Registered office
- 8300 Knokke-Heist
- Latest accounts
- 2025 · filed on 22 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Francois Claeys (SRL) has been based in Knokke-Heist since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 17,725 € and equity of 100,204 €; its revenue is not published. Its solvency stands at 46.0%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apotheek Francois Claeys
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Severin Retail sale of pharmaceutical products Sambreville · balance sheet 243,411 €
- Montpharma Retail sale of pharmaceutical products Forest · balance sheet 135,487 €
- Vivapharma Retail sale of pharmaceutical products Auderghem · balance sheet 236,296 €
- PTMS Consultancy Retail sale of pharmaceutical products Londerzeel · balance sheet 192,606 €
- Luc Thaens Retail sale of pharmaceutical products Heusden-Zolder · balance sheet 204,672 €
- Walpharma Retail sale of pharmaceutical products Arlon · balance sheet 202,753 €
- Melbuj Retail sale of pharmaceutical products Wemmel · balance sheet 237,909 €
- Adriaens-Louis Retail sale of pharmaceutical products Mons · balance sheet 402,839 €
Frequently asked questions about Apotheek Francois Claeys
What is the revenue of Apotheek Francois Claeys?
Apotheek Francois Claeys files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Francois Claeys?
In Belgium, the VAT number is the company number prefixed with BE: BE0775499855 for Apotheek Francois Claeys, if the company is VAT-registered. Its company number (CBE) is 0775.499.855.
Where is the registered office of Apotheek Francois Claeys?
According to the CBE register, the registered office of Apotheek Francois Claeys is in 8300 Knokke-Heist.
What is the equity of Apotheek Francois Claeys?
At the close of the 2025 financial year, the equity of Apotheek Francois Claeys amounts to 100,204 €, a solvency of 46.0% of total assets.
Who manages Apotheek Francois Claeys?
The register lists 2 active mandates at Apotheek Francois Claeys. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Francois Claeys
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →